March 15, 2022
Pittsburgh biotech company PeriphaGen Inc. reached a settlement to end litigation alleging its former lab partner, Krystal Biotech Inc., copied its gene therapy technology, with the deal worth at least $25 million and as high as $75 million, Krystal announced Monday.
May 04, 2020
Pittsburgh biotech company PeriphaGen Inc. is suing former lab partner Krystal Biotech Inc. in Pennsylvania federal court, claiming Krystal copied its gene therapy technology and used that to seek patents and investors.